NovaBay Pharma (NBY) Misses Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($1.37), $0.15 worse than the analyst estimate of ($1.22). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $3.15 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump: U.S. not seeking extension of Iran MOU
- Trump says North Korea's Kim responded to his outreach
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
